The Procter & Gamble Company Segment Reporting Other Item Amount
The Procter & Gamble Company (PG) reported Segment Reporting Other Item Amount of $629.00 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-04.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-04
- The Procter & Gamble Company segment reporting other item amount for the quarter ending 2026-06-30 was -$17.00M, a 110.18% decline year-over-year.
- The Procter & Gamble Company segment reporting other item amount for the quarter ending 2026-03-31 was $413.00M, a 300.97% increase year-over-year.
- The Procter & Gamble Company segment reporting other item amount for the quarter ending 2025-12-31 was $55.00M, a 47.12% decline year-over-year.
- The Procter & Gamble Company segment reporting other item amount for the quarter ending 2025-09-30 was $178.00M.
- The Procter & Gamble Company segment reporting other item amount for fiscal 2026 was $629.00M.
- The Procter & Gamble Company segment reporting other item amount for fiscal 2025 was -$284.00M.
- The Procter & Gamble Company segment reporting other item amount for fiscal 2024 was -$1.13B, a 613.70% decline from fiscal 2023.
- The Procter & Gamble Company segment reporting other item amount for fiscal 2023 was $219.00M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-04 | $396.00M derived: sum of 2 quarters · filed 2026-08-04 | $451.00M derived: sum of 3 quarters · filed 2026-08-04 | $629.00M 10-K · filed 2026-08-04 |
| 2026-03-31 | $413.00M 10-Q · filed 2026-04-24 | $468.00M derived: sum of 2 quarters · filed 2026-04-24 | $646.00M 10-Q · filed 2026-04-24 | $813.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $55.00M 10-Q · filed 2026-01-23 | $233.00M 10-Q · filed 2026-01-23 | $400.00M derived: sum of 3 quarters · filed 2026-08-04 | $503.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-09-30 | $178.00M 10-Q · filed 2025-10-24 | $345.00M derived: sum of 2 quarters · filed 2026-08-04 | $448.00M derived: sum of 3 quarters · filed 2026-08-04 | $552.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $167.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-04 | $270.00M derived: sum of 2 quarters · filed 2026-08-04 | $374.00M derived: sum of 3 quarters · filed 2026-08-04 | -$284.00M 10-K · filed 2026-08-04 |
| 2025-03-31 | $103.00M 10-Q · filed 2026-04-24 | $207.00M derived: sum of 2 quarters · filed 2026-04-24 | -$451.00M 10-Q · filed 2026-04-24 | |
| 2024-12-31 | $104.00M 10-Q · filed 2026-01-23 | -$554.00M 10-Q · filed 2026-01-23 | ||
| 2024-09-30 | -$657.00M 10-Q · filed 2025-10-24 | |||
| 2024-06-30 | -$1.13B 10-K · filed 2026-08-04 | |||
| 2023-06-30 | $219.00M 10-K · filed 2025-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |